The Preclinical Efficacy Of Ketogenic Diet In IDH1 Wild-type And Mutant Gliomas

被引：0
|
作者：
Javier, Rodrigo [1 ]
Mirkov, Snezana [1 ]
Horbinski, Craig [1 ]
机构：
[1] Northwestern Univ, Evanston, IL 60208 USA
来源：
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY | 2020年 / 79卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
50
引用
收藏
页码：667 / 667
页数：1
相关论文
共 50 条
  • [21] MOLECULAR PROFILING IDENTIFIES INCREASED TRANSGELIN-2 EXPRESSION IN LOW(ER) GRADE GLIOMAS WITH WILD-TYPE IDH1/2 VS. MUTANT IDH1/2
    Beyer, Sasha
    Bell, Erica H.
    McElroy, Joseph P.
    Oehkke, Oliver
    Fleming, Jessica
    Becker, Aline Paixao
    Cui, Tiantian
    Staszewski, Ori
    Prinz, Marco
    Grosu, Anca-Ligia
    Haque, S. Jaharul
    Chakravarti, Arnab
    NEURO-ONCOLOGY, 2017, 19 : 50 - 50
  • [22] Mutant IDH1 Prevents Thrombosis in Gliomas
    Horbinski, Craig
    Schwarze, Steven
    Khoury, Laith
    Thomas, Cheddhi
    Benjamin, Carolina
    Chen, Rui
    Dawson, Caleb
    Liu, Yinxing
    Song, Kristine
    Pacione, Donato
    Zagzag, David
    McIntyre, Thomas
    Snuderl, Matija
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2015, 74 (06): : 590 - 590
  • [23] Mutant IDH1 and tissue factor in gliomas
    Unruh, Dusten
    Mirkov, Snezana
    James, Charles D.
    Horbinski, Craig
    CANCER RESEARCH, 2017, 77
  • [24] IDH1-mutated gliomas rely on anaplerosis of glutamate and lactate whereas IDH1 wild-type gliomas rely on glycolysis and acetate anaplerosis
    Khurshed, Mohammed
    Lenting, Krissie
    Peeters, Tom
    Molenaar, Remco J.
    Leenders, William
    van Noorden, Cornelis
    FASEB JOURNAL, 2018, 32 (01):
  • [25] IDH1-mutated gliomas rely on anaplerosis of glutamate and lactate whereas IDH1 wild-type gliomas rely on glycolysis and acetate anaplerosis
    Khurshed, Mohammed
    Lenting, Krissie
    Molenaar, Remco J.
    Leenders, William P.
    van Noorden, Cornelis J.
    CANCER RESEARCH, 2017, 77
  • [26] Comparison of Transcriptomic Analysis between IDH1 Mutant and Wild-type of Lower Grade Glioma
    Lee, MinWook
    Jin, Hoeyoung
    Kim, Suwan
    Ji, SeonYeong
    Song, SeokJung
    Koh, DooHyun
    Choi, JoungWan
    Park, JeongMan
    Lee, YunGyeon
    Jo, GaeHoon
    Kim, JongIl
    Sim, JeongMin
    Ahn, JuWon
    Park, YoungJoon
    Kwack, KyuBum
    FASEB JOURNAL, 2020, 34
  • [27] IDH1 MUTATION SPECIFIC miRNA SIGNATURE PREDICTS FAVORABLE PROGNOSIS IN GLIOBLASTOMA WITH IDH1 WILD-TYPE
    Wang, Zheng
    Bao, Zhaoshi
    Jiang, Tao
    NEURO-ONCOLOGY, 2013, 15 : 91 - 91
  • [28] PLK1 INHIBITION ENHANCES TEMOZOLOMIDE EFFICACY IN IDH1 MUTANT GLIOMAS
    Bahassi, El Mustapha
    Koncar, Robert
    Chu, Zhengtao
    Qi, Chiaoyang
    Romick-Rosendale, Lindsey
    Wells, Susanne
    Chan, Timothy
    NEURO-ONCOLOGY, 2016, 18 : 68 - 68
  • [29] PLK1 inhibition enhances temozolomide efficacy in IDH1 mutant gliomas
    Koncar, Robert F.
    Chu, Zhengtao
    Romick-Rosendale, Lindsey E.
    Wells, SusanneI.
    Chan, Timothy A.
    Qi, Xiaoyang
    Bahassi, El Mustapha
    ONCOTARGET, 2017, 8 (09) : 15827 - 15837
  • [30] RNA-Binding Protein HuR Regulates Both Mutant and Wild-Type IDH1 in IDH1-Mutated Cancer
    Zarei, Mahsa
    Lal, Shruti
    Vaziri-Gohar, Ali
    O'Hayer, Kevin
    Gunda, Venugopal
    Singh, Pankaj K.
    Brody, Jonathan R.
    Winter, Jordan M.
    MOLECULAR CANCER RESEARCH, 2019, 17 (02) : 508 - 520
12345